
Timrå, Sweden
www.aiab.se
Aiab energy AB was founded in 1970 and is a supplier of system solutions for power supply, primarily within the fields of standby or backup power and mobile power generation systems. Aiab’s key offerings include automated backup power systems, single and/or parallel operated systems for stationary applications or as mobile modular systems, all within the 10-2500 kVA range.
Aiab is a leader in its field in Sweden and has approximately a 40% share of the relevant Swedish market. Its key customers include the Swedish Emergency Service Agency (MSB), the Stockholm Public Transport Agency (SL) and the Swedish military (FMV) to which Aiab has been an almost exclusive supplier for over 35 years. Although Aiab historically has focused on supplying the Swedish market, it has since 2006 been delivering to other countries, mainly portable power supply solutions to the Norwegian military.
Since 2012, Aiab is a qualified supplier of power supply equipment to the NSPA, the NATO Support and Procurement Agency and has several certified products with an NSN (NATO Stock Number) in NATO’s database. In 2015, Aiab signed an agreement with EATON regarding distribution in Scandinavia of their DC power solutions.
In 2015, Aiab increased its focus on the civilian market, thereby increasing the available market for its products in Sweden.
In 2021, Aiab signed new frame agreements with the Swedish Emergency Service Agency (MSB), the Stockholm Public Transport Agency (SL) and the Swedish Fortifications Agency (FMV).
All development, manufacturing and assembly is done by Aiab in its own factories in Timrå, north of Sundsvall, Sweden. The Company employs about 50 people and Allegro has been the majority owner since 2003.

Lund, Sweden
Alligator is a public company listed on the NASDAQ Nordic in Sweden.
Alligator is a research-based biotechnology company developing antibody-based pharmaceuticals for cancer treatment. The company specializes in the development of tumor-directed immunotherapies, in particular agonistic mono- and bispecific antibodies. In immunotherapy, the patients´ immune system is activated to cure cancer. The term tumor-directed means that the drug is administered or designed such that the pharmacological effect is localized to the tumor. This results in an advantageous efficacy and a safety profile with reduced side effects.
The company is primarily active in the early phases of drug development, from the idea stage to clinical phase II trials. This includes identification of innovative modes of action for pharmaceuticals, producing and optimizing new drug candidates, evaluation of preclinical efficacy and safety, and finally confirmatory clinical studies in cancer patients.
Alligator was founded in 2001 and is located at Medicon Village in Lund, Sweden.
Alligator currently has 45 employees
AnaMar AB
Lund, Sweden
www.anamar.com
AnaMar AB is a biopharmaceutical company focused on the discovery of novel therapeutic strategies to treat fibrotic diseases. The company is located at Medicon Village in Lund, Sweden.
AnaMar AB is developing the first selective 5-HT2B receptor antagonists with potential use in a number of human fibrotic diseases, e.g. Systemic Sclerosis, Idiopathic Pulmonary Fibrosis and Non-Alcoholic SteatoHepatitis. The compounds developed by AnaMar are of low molecular weight, the molecules are highly potent and highly selective and AnaMar owns the composition of matter intellectual property.
AnaMar has selected a candidate drug, AM1476, from its in-house molecules and is developing this molecule in the orphan indication Systemic Sclerosis, a serious disease currently lacking effective treatment. The selected candidate drug has successfully been evaluated in a phase I clinical trial in humans. AnaMar is currently preparing its entry into a large scale phase II proof-of-concept study.
AnaMar employs four people and Allegro has been the lead investor since 2002.
Gadelius Holding Ltd.
Tokyo, Japan
www.gadelius.com
Gadelius was founded in Japan in 1907 by entrepreneur Knut Gadelius; the company has Swedish roots but has always been a Japanese company. Since its first day, Gadelius has brought to the Japanese market not just industrial products, but the technologies that helped Japan throughout its modernization.
Today, Gadelius Holding Ltd. is the parent company uniting three specialized trading companies: Gadelius Industry K.K., Gadelius Medical K.K. and Gadelius Engineering K.K.
Gadelius Industry has extensive experience in disaster relief, low-energy housing, printing, industrial processing, food-processing and construction equipment. Recently it has focused more on introducing automated industrial process machinery that improves production efficiencies through robots and other technologies into the Japanese market.
Gadelius Medical brings innovative products from world-leading, long-established medical device manufacturers into the Japanese market. It has found success in distributing Through Pass®, its own OEM tube stents for endoscopic surgery, a product which greatly increases the quality of life for patients.
Gadelius Engineering brings a range of advanced technological products into Japan on a licensing basis, including the EMAS bed of Runway Safe. Runway Safe’s Green EMAS technology, which safely stops aircraft overruns on runways, was successfully introduced at Tokyo’s Haneda Airport in 2019 and is expected to be introduced at several other Japanese airports.
The Gadelius Group employs about 230 people in locations throughout Japan. Allegro has been an investor in the company since 2006.
GovX, Inc.
San Diego, USA
www.govx.com
GovX is an eCommerce company built on a foundation of respect and appreciation for the US Military, Law Enforcement and First Responder communities. Verified GovX members receive exclusive access to an expansive catalog with the best prices on premium brands for on-duty and off-duty needs. Members-only savings are also available on travel services, sports tickets and entertainment options for the entire family.
The platform is secured with GovX ID, a proprietary user identification platform that verifies eligibility and restricts access to approved members only. This closed-channel approach allows brands to offer favorable pricing and build a deeper relationship with those who serve, without disrupting their other retail channels. GovX also licenses this proprietary service to partners who wish to offer discounts on their own site to this deserving community.
The company was founded in 2010 and has its offices in San Diego, California. It has 87 employees and Allegro has been a key investor since 2013.
Harbour Advisors Cayman Ltd.
Grand Cayman, Cayman Islands
www.harbourlitigationfunding.com
Harbour Advisors Cayman Ltd. serves as the investment advisor to a number of Harbour investment funds that in total has over £1.2 billion in partner commitments.
Harbour, through its sub-advisors, Harbour Litigation Funding Ltd. and its parent, Harbour Solutions Group provides investment advisory, portfolio management and other services to the Harbour investment funds relating to litigation, arbitration and other dispute resolution mechanisms, as well as collections and enforcements of judgements. Harbour’s approach is to combine legal, financial and investment expertise in assessing claims for potential investment by its funds.
The services provided by Harbour to its investment funds include recommending Claims, the provision of advice in respect to Claims and the on-going monitoring and review of Claims invested in by its investment funds.
Allegro is one of the initial founders of Harbour and has been invested in Harbour since 2009. Harbour and HLF together employ about 31 people.
INQO Investments (Pty) Ltd.
Cape Town, South Africa
www.Inqo.co.za
Inqo is an impact investment company investing in businesses that tackle poverty and the social needs of the poor. Inqo believes that enterprise is the best way to tackle poverty through creating sustainable employment that empowers the poor and transforms communities. Whilst aid and philanthropy will always have a role in humanitarian crises, Inqo believes that sustainable transformation of low-income countries can only be achieved through economic development.
As a social venture investment company, Inqo invests in businesses that create jobs, provide services and products for the poor as well as tackle environmental issues. Inqo invests mostly in small to medium size enterprises (SMEs) that are scalable and have potential for growth and asset appreciation. In addition to the financial returns, each investment will be monitored for their measurable social and environmental impact. Our primary investment focus is Sub-Saharan Africa.
Inqo’s current portfolio companies include the 40,000 acre Kuzuko Private Game Reserve (South Africa), a five star luxury resort based in the Eastern Cape, which combines job creation, conservation and transformation managed by a team of 60 people; Spekboom Trading (South Africa), a project involving the re-forestation of 14,000 acres with the indigenous Spekboom plant in the Eastern Cape to restore degraded land, create 250+ jobs and generate carbon trading credits; Bee Sweet Honey Ltd (Zambia), a commercial producer of forest honey with 90,000 beehives using a network of 10,000 small farmers in Northern Zambia exporting around 350 metric tons a year from a factory employing 30 people; Mazima Retirement Plan (Uganda), a voluntary retirement and housing savings scheme for low-income earners in the informal economy; Southlake Medical Centre (Kenya), providing primary and secondary health care to the 50,000 flower farm workers in Naivasha and Kentegra (Kenya) with 50 staff; Kentegra (Kenya) producing organic pyrethrum insecticide working with 7,000 out-growers, employing 150 people; Sanergy (Kenya) with 3700 franchise toilets serving 140,000 people daily and a factory with a capacity of processing 70,000 metric tons of waste annually into Black Soldier Fly insect protein and organic fertilizer, employing over 500 people.
Allegro first invested in Inqo in 2014 and has made several follow-on investments as the company has continued to grow.

Tallinn, Estonia
Wujang(Suzhou), China
www.jtk-power-group.com
www.jtk-power-finland.com
www.jtk-power-estonia.com
www.jtk-power-china.com
The JTK Power Group specializes in manufacturing complex steel solutions for the world’s leading companies in the marine and mining industries, the logistics sector, the power plant industry and the building sector. JTK has a footprint in Central and Northern Europe and in China and is able to offer comprehensive solutions for a broad range of systems globally.
The factories are located in the Vaasa region in Western Finland (2), in Suzhou in China and close to Tallinn in Estonia. Products can be found on every continent, in as many as 160 countries. With more than 20 years of operation, the group has supplied more than 30,000 silencers and offered various project solutions to companies all over the world.
The JTK Power Group aims to have the best worldwide technology know-how in its field in the world along with 100% delivery reliability and dimensional accuracy of its products. The products are designed to withstand extreme conditions because they have to work equally well in hot, cold, wet and humid conditions. By combining customers’ needs with JTK’s technical know-how it creates products of the highest quality.
Allegro acquired JTK in August of 2013 and the group employs over 200 people.

Koncentra Pistons designs, manufactures and markets large bore pistons for leading manufacturers of medium speed diesel and gas engines. Large bore engines used in marine applications, as well as, in power plants, are exposed to severe combustion conditions. Such combustion environments require pistons that can resist high combustion pressure, high temperatures, heavy wear and extreme corrosive conditions.
Koncentra Pistons is applying proprietary state-of-the art R&D Technology to design piston structures, cooling systems, surface treatment and manufacturing processes of pistons and has invested in the most advanced CNC and Automation Technology for efficient and quality assured manufacturing.
Koncentra Pistons’ technology provides the best possible performance by achieving outstanding ring groove wear, excellent support surface performance, light structure, improved fatigue strength and cost competitiveness.
Koncentra Pistons is approved by ISO 9001, ISO 14001 and OHSAS 18001.
The company was founded in 1997 and employs about 40 people. Allegro acquired the company in August of 2016.
Malmstens Verkstad AB was founded in 1969 and is a subcontractor of large and heavy products within the area of CNC-machining, welding, robot-welding and assembly.
The company has extensive experience in partnering with large industrial organizations in manufacturing both semi-finished and finished steel components for industrial use. Malmstens is equipped to handle requests for large and heavy-duty components and can manufacture using any method and type of material.
Malmstens Verkstad AB is certified by ISO 9001, ISO 14001, EN 1090-1 and ISO 3834-2.
Malmstens Verkstad AB employs about 40 people and Allegro became the principal owner in 2010.
Nclear is committed to restoring nature’s equilibrium to the world’s water bodies by addressing the problem of nutrient pollution (excess levels of phosphorus and nitrogen) that is causing toxic algae and red tide blooms across the globe.
Nclear’s patented TPX™ nanocrystal technology helps wastewater plants meet more stringent phosphorus discharge limits with an efficient and cost-effective solution that eliminates the need for toxic chemicals. Any resulting solid waste is non-toxic and can often be repurposed rather than sent to landfills. TPX™ is a patented synthetic calcium-silicate mineral engineered to be the most cost effective and environmentally safe solution to remove phosphorus and certain other contaminants from industrial processes, as well as to remove or prevent excess phosphorus concentrations from water bodies such as lakes, rivers, streams, estuaries and bays.
In addition, Nclear’s proprietary ElectrX™ electrochemical reactor technology is a cost-effective and environmentally friendly way to eliminate excess nitrogen levels in wastewaters, by converting ammonia to harmless nitrogen gas.
The company has 12 employees and Allegro has been the lead investor since 2015.
Oxymetal, which was founded in 1984, is a European leader in industrial metal cutting.
With operations in France and Czech Republic, Oxymetal’s core business is in metal cutting with a wide range of services from high-precision laser cutting from as little as 0.1 mm to the cutting of very thick pieces of up to 400 mm. In addition, Oxymetal offers finishing operations, such as bending, machining and welding and is versatile enough to handle everything from one-off prototypes to serial production of finished components or sub-assemblies.
Oxymetal has a very diversified customer base supplying many different industries including energy, aerospace, medical equipment, automotive, railroad, construction, industrial machinery and equipment.
The company employs about 400 people. Allegro invested in Oxymetal in 2012 and became the majority owner in 2020.
Sight Sciences is a commercial-stage medical device company dedicated to the development and sale of intelligently designed and engineered products that address the underlying physiology of ophthalmic diseases. The company currently operates in two markets – glaucoma and dry eye disease.
Sight Sciences’ OmniTM surgical device is the first comprehensive MIGS device cleared for use in the U.S. and EU across the spectrum of primary open-angle glaucoma (POAG) patients. There are over 4 million in the U.S. and over 65 million worldwide. The OMNI system is used for canaloplasty (microcatheterization and transluminal viscodilation of Schlemm’s canal) followed by trabeculotomy (cutting of trabecular meshwork) to reduce intraocular pressure (IOP) in adult POAG patients. The differentiated OMNI Surgical System uniquely targets all three points of resistance (trabecular meshwork, Schlemm’s canal and collector channels) in the conventional outflow pathway. The procedure is implant-free and canal-based, offering ophthalmic surgeons and patients a safe and effective device for reducing IOP in adult primary open-angle glaucoma patients.
The company has also developed a device designed to treat dry eye disease. The TearCare® System is a wearable, open eye and fully customizable eyelid technology which has been available commercially since a controlled launch in mid-2019. TearCare® is a software-controlled technology that provides targeted and adjustable thermal energy to the meibomian glands, leveraging the full functionality of the blinking eye. The TearCare® System’s proprietary iLid™ technology facilitates natural meibum expression when meibum is in its melted phase.
Sight Sciences was founded in 2011 and Allegro was one of the initial investors in the company’s Series A round. After also participating in the Series B offering, Allegro led the company’s Series C round in 2018 and Staffan Encrantz joined the Board as Chairman.
Sight Sciences is headquartered in Menlo Park, California and currently has about 175 employees.
Zymbit is an innovator in secure embedded computing solutions that protect sensitive IP, data and credentials in commercial, financial and industrial applications.
The company’s modular security products reduce the loss of critical digital assets by providing multiple layers of digital and physical security to board compute platforms. Zymbit products are designed to be easy to integrate by software developers and ready to scale in high volume manufacture.
Zymbit products are used by OEMs and integrators in the US and Europe for applications that include medical diagnostics, energy distribution, building management and industrial monitoring.
Zymbit was founded in 2014 and Allegro led a Series-A financing in early 2020 to fund the development of a growing pipeline of multi-million dollar OEM projects.
Zymbit currently has 10 employees.